ArticleThe Journal of clinical investigation2013
MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
Jennifer Schlegel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
100 papers cite itlatest 60 shown
this paperpooled itcites it